Stanley-Laman Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.44M | Sell |
71,877
-544
| -0.8% | -$48.6K | 0.76% | 34 |
|
|
2026
Q1 | $5.2M | Buy |
72,421
+1,981
| +3% | +$153K | 0.64% | 53 |
|
|
2025
Q4 | $5.59M | Buy |
70,440
+3,664
| +5% | +$289K | 0.71% | 34 |
|
|
2025
Q3 | $5.03M | Sell |
66,776
-477
| -0.7% | -$32.7K | 0.72% | 38 |
|
|
2025
Q2 | $4.64M | Sell |
67,253
-12,274
| -15% | -$805K | 0.69% | 50 |
|
|
2025
Q1 | $5.39M | Sell |
79,527
-1,145
| -1% | -$68.5K | 0.83% | 26 |
|
|
2024
Q4 | $3.62M | Buy |
80,672
+75,172
| +1,367% | +$4.22M | 0.51% | 85 |
|
|
2024
Q3 | $346K | Hold |
5,500
| – | – | 0.05% | 234 |
|
|
2024
Q2 | $325K | Sell |
5,500
-1,333
| -20% | -$83.4K | 0.05% | 229 |
|
|
2024
Q1 | $545K | Hold |
6,833
| – | – | 0.08% | 182 |
|
|
2023
Q4 | $540K | Hold |
6,833
| – | – | 0.08% | 178 |
|
|
2023
Q3 | $477K | Hold |
6,833
| – | – | 0.08% | 177 |
|
|
2023
Q2 | $472K | Hold |
6,833
| – | – | 0.08% | 176 |
|
|
2023
Q1 | $508K | Hold |
6,833
| – | – | 0.09% | 175 |
|
|
2022
Q4 | $637K | Hold |
6,833
| – | – | 0.12% | 163 |
|
|
2022
Q3 | $652K | Hold |
6,833
| – | – | 0.12% | 165 |
|
|
2022
Q2 | $633K | Hold |
6,833
| – | – | 0.11% | 186 |
|
|
2022
Q1 | $692K | Hold |
6,833
| – | – | 0.1% | 192 |
|
|
2021
Q4 | $705K | Hold |
6,833
| – | – | 0.08% | 213 |
|
|
2021
Q3 | $580K | Hold |
6,833
| – | – | 0.08% | 216 |
|
|
2021
Q2 | $570K | Buy |
6,833
+500
| +8% | +$40.9K | 0.08% | 211 |
|
|
2021
Q1 | $476K | Sell |
6,333
-1,677
| -21% | -$122K | 0.08% | 212 |
|
|
2020
Q4 | $547K | Sell |
8,010
-12,595
| -61% | -$819K | 0.1% | 201 |
|
|
2020
Q3 | $1.2M | Sell |
20,605
-2,320
| -10% | -$144K | 0.27% | 108 |
|
|
2020
Q2 | $1.49M | Buy |
22,925
+3,059
| +15% | +$193K | 0.36% | 71 |
|
|
2020
Q1 | $1.18M | Sell |
19,866
-1,943
| -9% | -$130K | 0.36% | 76 |
|
|
2019
Q4 | $1.62M | Sell |
21,809
-415
| -2% | -$29.1K | 0.38% | 72 |
|
|
2019
Q3 | $1.4M | Sell |
22,224
-235
| -1% | -$13.9K | 0.35% | 84 |
|
|
2019
Q2 | $1.22M | Sell |
22,459
-4,508
| -17% | -$243K | 0.29% | 102 |
|
|
2019
Q1 | $1.45M | Buy |
26,967
+4,595
| +21% | +$284K | 0.35% | 79 |
|
|
2018
Q4 | $1.47M | Sell |
22,372
-2,723
| -11% | -$203K | 0.41% | 73 |
|
|
2018
Q3 | $1.98M | Sell |
25,095
-795
| -3% | -$56.8K | 0.49% | 64 |
|
|
2018
Q2 | $1.67M | Sell |
25,890
-796
| -3% | -$52.5K | 0.37% | 84 |
|
|
2018
Q1 | $1.66M | Sell |
26,686
-1,799
| -6% | -$129K | 0.38% | 86 |
|
|
2017
Q4 | $2.06M | Sell |
28,485
-9,811
| -26% | -$713K | 0.45% | 78 |
|
|
2017
Q3 | $3.11M | Sell |
38,296
-4,993
| -12% | -$395K | 0.83% | 39 |
|
|
2017
Q2 | $3.48M | Buy |
43,289
+34,448
| +390% | +$2.72M | 0.94% | 32 |
|
|
2017
Q1 | $694K | Sell |
8,841
-5,033
| -36% | -$402K | 0.19% | 130 |
|
|
2016
Q4 | $1.09M | Buy |
13,874
+4,785
| +53% | +$387K | 0.34% | 107 |
|
|
2016
Q3 | $809K | Buy |
9,089
+894
| +11% | +$84.4K | 0.33% | 109 |
|
|
2016
Q2 | $785K | Buy |
8,195
+1,937
| +31% | +$193K | 0.31% | 128 |
|
|
2016
Q1 | $649K | Sell |
6,258
-8,709
| -58% | -$847K | 0.12% | 157 |
|
|
2015
Q4 | $1.46M | Buy |
14,967
+8,484
| +131% | +$831K | 0.25% | 109 |
|
|
2015
Q3 | $625K | Hold |
6,483
| – | – | 0.13% | 170 |
|
|
2015
Q2 | $680K | Hold |
6,483
| – | – | 0.12% | 169 |
|
|
2015
Q1 | $669K | Buy |
6,483
+171
| +3% | +$17.3K | 0.12% | 177 |
|
|
2014
Q4 | $608K | Buy |
6,312
+877
| +16% | +$77.3K | 0.12% | 190 |
|
|
2014
Q3 | $433K | Hold |
5,435
| – | – | 0.08% | 215 |
|
|
2014
Q2 | $410K | Hold |
5,435
| – | – | 0.08% | 223 |
|
|
2014
Q1 | $407K | Buy |
+5,435
| New | +$384K | 0.07% | 222 |
|
Other funds holding CVS
Stanley-Laman Group's CVS Position: Q2 2026 in Review
Stanley-Laman Group reduced its CVS Health (CVS) stake by 0.75% in Q2 2026, selling an estimated $48.6K and leaving 71,877 shares worth $7.44M. The position accounts for 0.76% of the portfolio, ranked #34.
Stanley-Laman Group first reported a position in CVS in Q1 2014 and has held it in 50 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Stanley-Laman Group held 71,877 shares of CVS Health worth $7.44M as of Q2 2026.
- Stanley-Laman Group sold 544 CVS Health shares in Q2 2026, an estimated $48.6K.
- CVS Health made up 0.76% of Stanley-Laman Group's portfolio in Q2 2026, its #34 holding.
- Stanley-Laman Group first reported a position in CVS Health in Q1 2014 and has held it in 50 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Stanley-Laman Group's 13F filing for Q2 2026, filed 5 Aug 2026.